Genomic Correlates of Exceptional Response to ErbB3 Inhibition in Head and Neck Squamous Cell Carcinoma

Daniel L. Faden(Broad Institute), Umamaheswar Duvvuri(City University of New York), Diego Alvarado(Unknown), Roberto Gomez-Casal(UPMC Hillman Cancer Center)

JCO Precision Oncology

March 25, 2019

10.1200/po.18.00174

Cited by 3

Related Papers

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

|Immunity|2020|688

Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

|Cancer Discovery|2013|590

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

|Cancer|2014|502

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

|Thyroid|2015|393

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

|Nature Communications|2021|365